13F-HR filed by TAKEDA PHARMACEUTICAL CO LTD
TAKEDA PHARMACEUTICAL CO LTD filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-13, with 8 holding rows worth $16,369,175.
- Accession
- 0001395064-25-000157
- Filer
- CIK 1395064
- Filed
- 2025-11-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2025
A holdings report, 9 entries on the cover page, a total value of $16,369,175 stated on the cover page (in dollars after the unit check, H1), rows summing to $16,369,175 with VALUE read as dollars as filed, 13F file number 028-24938. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerTakeda Vaccines, Inc. 028-24939
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 7,531,996 | $9,791,595 | dollars as filed | |
| EQUILLIUM INC | 29446K106 | COM | 1,824,977 | $2,609,717 | dollars as filed | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 1,475,121 | $1,243,084 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 515,619 | $1,232,329 | dollars as filed | |
| LYELL IMMUNOPHARMA INC | 55083R104 | COM | 54,887 | $891,365 | dollars as filed | |
| AMERICAN WELL CORP | 03044L204 | COM CL A NEW | 77,733 | $478,061 | dollars as filed | |
| RANI THERAPEUTICS HLDGS INC | 753018100 | CMN | 203,190 | $101,554 | dollars as filed | |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 16,515 | $21,470 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001395064-25-000157 | this filing | 2025-11-13 | acceptance time not in the bulk data set |